1. Home
  2. Analysis
  3. Coreg
  4. Entyvio

Coreg and Entyvio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Entyvio (vedolizumab). Common drug interactions include abdominal pain among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Entyvio. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

On Jul, 14, 2026

11 people who take Coreg and Entyvio together, and have interactions are studied.

Coreg and Entyvio drug interactions.

What are the common drug interactions of Coreg and Entyvio, by gender? *:

female:

  1. Abdominal pain
  2. Alopecia (absence of hair from areas of the body)
  3. Arthralgia (joint pain)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Flushing (the warm, red condition of human skin)
  6. Gingival bleeding (bleeding gums)
  7. Rash
  8. Constipation
  9. Weight increased
  10. Infusion site erythema (reddening of the skin at infusion site)

male:

  1. Death
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Confusional state

What are the common drug interactions of Coreg and Entyvio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Constipation
  2. Weight increased

50-59:

n/a

60+:

  1. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 2 people, 18.18%
  2. Immunodeficiency Common Variable: 2 people, 18.18%
  3. Cardiac Disorder: 2 people, 18.18%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
  5. Transplant Rejection (a transplant material is not worked): 1 person, 9.09%
  6. Leukaemia (blood or bone marrow cancer): 1 person, 9.09%
  7. High Blood Cholesterol: 1 person, 9.09%
  8. Depression: 1 person, 9.09%
  9. Anaemia (lack of blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Entyvio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coreg and Entyvio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Entyvio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coreg and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Entyvio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and vedolizumab (the active ingredients of Coreg and Entyvio, respectively), and Coreg and Entyvio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.